| （単位：千ドル） | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 3,875 | 5,027 | 8,539 | 8,759 | 11,295 | 14,304 | 15,730 | 17,064 | 13,257 | 9,801 | 10,516 | 11,876 | 15,377 |
| 営業費用 | 5,680 | 7,687 | 11,337 | 13,370 | 15,639 | 19,192 | 21,651 | 22,596 | 18,822 | 14,400 | 15,043 | 16,246 | 20,418 |
| 営業利益 | -5,680 | -7,687 | -11,337 | -13,370 | -15,639 | -19,192 | -21,651 | -22,596 | -18,822 | -14,400 | -15,043 | -16,246 | -20,418 |
| 純利益 | -5,514 | -7,636 | -11,318 | -13,265 | -14,999 | -17,704 | -19,294 | -19,937 | -15,789 | -11,105 | -11,793 | -13,039 | -17,715 |
| 一株あたり利益 | - | - | - | - | -0.27 | -0.32 | -0.35 | -0.36 | -0.28 | -0.2 | -0.21 | -0.23 | -0.31 |
| 希薄化後一株あたり利益 | - | - | - | - | -0.27 | -0.32 | -0.35 | -0.36 | -0.28 | -0.2 | -0.21 | -0.23 | -0.31 |